XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statements of Changes in Stockholders’ Equity (Unaudited) - USD ($)
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2021 $ 2,011 $ 28,074,484 $ (7,694,786) $ 20,381,709
Balance (in Shares) at Dec. 31, 2021 20,112,244      
Impact of adoption of ASC 842 (5,368) (5,368)
Impact of adoption of ASC 842 (in Shares)      
Stock-based compensation expense 126,086 126,086
Stock-based compensation expense (in Shares)      
Exercise of common stock Series B Warrants $ 4 (4)
Exercise of common stock Series B Warrants (in Shares) 39,000      
Net loss (2,013,403) (2,013,403)
Net loss      
Balance at Mar. 31, 2022 $ 2,015 28,200,566 (9,713,557) 18,489,024
Balance (in Shares) at Mar. 31, 2022 20,151,244      
Balance at Dec. 31, 2022 $ 2,022 28,536,353 (16,997,102) 11,541,273
Balance (in Shares) at Dec. 31, 2022 20,215,288      
Stock-based compensation expense 54,730 54,730
Stock-based compensation expense (in Shares)      
Grants of fully vested restricted stock units to settle accrued bonus, net of shares withheld $ 24 107,234 107,234
Grants of fully vested restricted stock units to settle accrued bonus, net of shares withheld (in Shares) 243,769      
Net loss (2,539,843) (2,539,843)
Net loss      
Balance at Mar. 31, 2023 $ 2,046 $ 28,698,317 $ (19,536,945) $ 9,163,418
Balance (in Shares) at Mar. 31, 2023 20,459,057